HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jin Huang Selected Research

IQ motif containing GTPase activating protein 1

11/2014Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation.
12/2013IQGAP1 plays an important role in the cell proliferation of multiple myeloma via the MAP kinase (ERK) pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:
Type Validation Code Shown:


Jin Huang Research Topics

Disease

54Neoplasms (Cancer)
01/2016 - 05/2005
7Stomach Neoplasms (Stomach Cancer)
01/2015 - 10/2009
6Inflammation
11/2015 - 05/2005
6Asthma (Bronchial Asthma)
12/2012 - 01/2007
5Pain (Aches)
12/2015 - 08/2003
5Malaria
04/2014 - 01/2009
4Glioma (Gliomas)
09/2015 - 10/2014
4Carcinoma (Carcinomatosis)
01/2015 - 05/2005
4Prostatic Neoplasms (Prostate Cancer)
01/2015 - 01/2011
4Multiple Myeloma
11/2014 - 10/2007
4Hepatocellular Carcinoma (Hepatoma)
04/2014 - 02/2005
4Lung Neoplasms (Lung Cancer)
10/2013 - 01/2011
3Neurodegenerative Diseases (Neurodegenerative Disease)
04/2015 - 07/2014
3Neoplasm Metastasis (Metastasis)
01/2015 - 08/2007
3Wounds and Injuries (Trauma)
01/2015 - 01/2010
3Ischemia
12/2014 - 03/2005
3Chronic Obstructive Pulmonary Disease (COPD)
02/2014 - 08/2011
3Infection
09/2012 - 12/2002
3Tuberculosis (Tuberculoses)
01/2012 - 05/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2015 - 05/2005
2Immune System Diseases (Immune Disorders)
12/2014 - 09/2012
2Dyslipidemias (Dyslipidemia)
07/2014 - 04/2011
2Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 10/2011
2Esophageal Stenosis (Esophageal Stricture)
01/2014 - 01/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2014 - 01/2014
2Acquired Immunodeficiency Syndrome (AIDS)
05/2013 - 12/2012
2Diabetes Mellitus
09/2012 - 09/2009
2Body Weight (Weight, Body)
04/2012 - 01/2012
2Breast Neoplasms (Breast Cancer)
01/2012 - 01/2011
2Alzheimer Disease (Alzheimer's Disease)
04/2011 - 07/2004
2Necrosis
09/2009 - 10/2007
1Chromosome Aberrations (Chromosome Abnormalities)
12/2015
1Aneuploidy (Aneuploid)
12/2015
1Pulpitis
12/2015
1Insulin Resistance
11/2015
1Atherosclerosis
11/2015
1Genomic Instability
11/2015
1Osteoporosis
09/2015

Drug/Important Bio-Agent (IBA)

9MicroRNAs (MicroRNA)IBA
06/2015 - 09/2011
6MicellesIBA
09/2015 - 07/2011
6Proteins (Proteins, Gene)IBA
06/2013 - 05/2005
5Messenger RNA (mRNA)IBA
01/2016 - 01/2009
5Biological Markers (Surrogate Marker)IBA
06/2015 - 06/2012
4Prostaglandins D (PGD)IBA
12/2015 - 10/2007
4Drug CarriersIBA
09/2015 - 07/2011
4PolymersIBA
10/2013 - 04/2009
3Hematoxylin (Haematoxylon)IBA
12/2015 - 10/2009
3salicylhydroxamic acid (SHAM)IBA
12/2015 - 10/2009
3Eosine Yellowish-(YS) (Eosin)IBA
12/2015 - 10/2009
3Carbon MonoxideIBA
11/2015 - 05/2005
3monomethoxypolyethylene glycol (MPEG)IBA
09/2015 - 05/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 06/2013
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2014 - 10/2007
3Antimalarials (Antimalarial Agents)IBA
04/2014 - 01/2012
3DNA (Deoxyribonucleic Acid)IBA
06/2013 - 02/2005
3PlatinumIBA
05/2013 - 04/2009
2LigandsIBA
12/2015 - 05/2005
2gemcitabineFDA Link
11/2015 - 04/2015
2Glucose (Dextrose)FDA LinkGeneric
11/2015 - 01/2015
2UbiquitinIBA
11/2015 - 05/2005
2tebufenozide (Mimic)IBA
09/2015 - 05/2005
2CytokinesIBA
09/2015 - 01/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2015 - 09/2009
2NanocapsulesIBA
04/2015 - 03/2014
2dihydroorotate dehydrogenaseIBA
02/2015 - 10/2013
2Insulin (Novolin)FDA Link
01/2015 - 04/2012
2Histones (Histone)IBA
01/2015 - 04/2012
2IQ motif containing GTPase activating protein 1IBA
11/2014 - 12/2013
2Phosphotransferases (Kinase)IBA
11/2014 - 12/2013
2Cisplatin (Platino)FDA LinkGeneric
01/2014 - 09/2011
2VaccinesIBA
10/2013 - 09/2012
2Verapamil (Calan)FDA LinkGeneric
10/2013 - 03/2011
2AdiponectinIBA
01/2013 - 01/2012
2Nasopharyngeal carcinomaIBA
01/2013 - 03/2012
2VimentinIBA
12/2012 - 09/2009
2Morphine (MS Contin)FDA LinkGeneric
09/2012 - 01/2009
2AntigensIBA
09/2012 - 11/2009
2LeptinIBA
04/2012 - 01/2012
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2012 - 05/2005
2AntibodiesIBA
06/2011 - 10/2008
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2011 - 01/2010
2Transforming Growth Factor beta (TGF-beta)IBA
02/2010 - 05/2005
2Chemokine CCL5IBA
01/2010 - 01/2010
2PPAR gammaIBA
09/2009 - 03/2008
2Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2008 - 10/2007
2puerarinIBA
04/2005 - 03/2005
1delta Opioid Receptors (delta Opioid Receptor)IBA
12/2015
1alpha-tocopheryl polyethylene glycol succinateIBA
11/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2015
1resveratrolIBA
09/2015
1Cathepsin BIBA
09/2015
1Interleukin-6 (Interleukin 6)IBA
09/2015
1C-Reactive ProteinIBA
09/2015
1methyl cellosolve (ethylene glycol monomethyl ether)IBA
09/2015
1Valine (L-Valine)FDA Link
09/2015
1CitrullineIBA
09/2015

Therapy/Procedure

7Drug Therapy (Chemotherapy)
01/2015 - 03/2011
4Radiotherapy
01/2015 - 10/2013
3Lasers (Laser)
01/2015 - 02/2005
1Intravenous Injections
11/2015